BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Tuesday, April 7, 2026
Home » Authors » Liz Hollis

Articles by Liz Hollis

Early study results prove positive for Abbott's Tendyne TMVR system

May 24, 2018
By Liz Hollis

Pulmonx's Zephyr endobronchial valve shows promise for patients with severe emphysema

May 23, 2018
By Liz Hollis
As it awaits a decision from the FDA on its PMA, Pulmonx Corp. touted positive one-year results from the U.S. LIBERATE pivotal trial of the Zephyr endobronchial valve for severe emphysema, including statistically significant reduction in the rate of respiratory failure in patients receiving the device. If approved, the therapy would offer a new choice for patients with limited options and who experience a poor quality of life.
Read More

Edwards highlights positive real-world evidence for Sapien 3 transcatheter heart valve

May 23, 2018
By Liz Hollis

FDA gives nod to Cerenovus for Embotrap II

May 22, 2018
By Liz Hollis
Cerenovus, a unit of New Brunswick, N.J.-based Johnson & Johnson Corp. (J&J), received 510(k) clearance for the Embotrap II to capture and remove blood clots from the brain following an ischemic stroke.
Read More

Stimguard wins CE mark for system to treat OAB

May 18, 2018
By Liz Hollis
Privately held Stimguard LLC has received CE mark approval for its sacral nerve stimulation (SNS) system to treat the chronic, intractable symptoms of overactive bladder (OAB). Pompano Beach, Fla.-based Stimguard has projected that the device will be available this summer.
Read More

Auris Health inks robotic development, commercialization deal with Neuwave

May 17, 2018
By Liz Hollis
With the field of robotic surgery continuing to heat up, Auris Health Inc. has entered a cooperative development and commercialization agreement with Neuwave Medical Inc., a subsidiary of Johnson & Johnson's (J&J) Ethicon Inc., focused on robotically assisted bronchoscopic ablation of lesions in the lung.
Read More

Cepheid scores expanded claims for Xpert test

May 16, 2018
By Liz Hollis
The FDA has cleared expanded claims for the Xpert Carba-R, a molecular test for the detection of carbapenemase-producing gram-negative bacteria, from Sunnyvale, Calif.-based Cepheid Inc. The additional claims extend use to the analysis of perirectal swab specimens, allowing test results to guide therapeutic strategies for pure colonies.
Read More

Real-world data backs Boston Scientific's Smart Pass in reducing inappropriate shocks

May 15, 2018
By Liz Hollis
The Smart Pass sensing filter reduced the risk of all inappropriate shocks from the Emblem subcutaneous implantable defibrillator (S-ICD) system by 68 percent, according to real-world data presented at Heart Rhythm 2018, the Heart Rhythm Society's 39th Annual Scientific Sessions in Boston. These results came from an analysis of the Latitude database to assess how the use of the Smart Pass in patients implanted with the Emblem S-ICD. The analysis of Boston Scientific's device also was published online in the Heart Rhythm Journal.
Read More

CMS ups payment rates for DME, industry group wants additional action

May 14, 2018
By Liz Hollis

FDA outlines progress with software pre-cert program, seeks industry input

May 11, 2018
By Liz Hollis
Previous 1 2 … 53 54 55 56 57 58 59 60 61 … 67 68 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for April 7, 2026.
  • Hengrui discovers new Nav1.8 blockers

    BioWorld Science
    Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for April 7, 2026
  • Cancer and blood cells

    Hematopoietic stem cell research points to leukemia’s early roots

    BioWorld Science
    Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
  • 3D illustration of antibodies

    Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis

    BioWorld Science
    Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing